High ROR1 Expression Is Associated With Poor Differentiation and Perineural Invasion in Cutaneous Squamous Cell Carcinoma
Experimental Dermatology · 2025
DOI: 10.1111/exd.70185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Yannick Foerster und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Receptor Tyrosine Kinase-like Orphan Receptors, Skin Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cutaneous squamous cell carcinoma (cSCC) is a common type of skin cancer, predominantly affecting elderly and immunosuppressed patients. Despite recent therapeutic advances, including the introduction of immune checkpoint inhibitors, outcomes for patients with metastatic or recurrent disease remain poor, underscoring the need for new therapeutic approaches and reliable biomarkers to identify patients at high risk of progression. In this context, receptor tyrosine kinase‐like orphan receptor 1 (ROR1), previously associated with poor prognosis and targeted therapeutically in other malignancies, has not yet been investigated in cSCC. This study aimed to evaluate ROR1 expression in cSCC and investigate its potential role as a biomarker for tumour aggressiveness. ROR1 expression was analysed via immunofluorescence in a tissue microarray of 360 cSCC samples from a biobank cohort at the University Hospital Cologne. Fluorescence intensity was quantified and correlated with clinicopathologic features and patient outcomes. High ROR1 expression was detected in 42.5% of samples, predominantly localised at tumour invasive fronts. Elevated ROR1 levels were significantly associated with poor tumour differentiation ( p < 0.001), lymph node metastasis ( p = 0.007), and perineural invasion ( p = 0.005). Although higher ROR1 expression correlated with worse progression‐free and metastasis‐free survival, these differences did not reach statistical significance. In conclusion, this study identifies ROR1 as a novel marker of aggressive cSCC, linked to poor differentiation, lymphatic spread and perineural invasion. ROR1 holds potential both as a prognostic biomarker and as a therapeutic target, encouraging future exploration of ROR1‐directed therapies in advanced cSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
- Department of Dermatology, University Hospital Cologne and Medical Faculty, Cologne, Germany.
ORCID-Profile: Yannick Foerster, Kristine E Mayer, Oana-Diana Persa
Zitieren
APA
Foerster, Y., Mayer, K. E., Biedermann, T., & Persa, O. D. (2025). High ROR1 Expression Is Associated With Poor Differentiation and Perineural Invasion in Cutaneous Squamous Cell Carcinoma. Experimental Dermatology. https://doi.org/10.1111/exd.70185
Vancouver
Foerster Y, Mayer KE, Biedermann T, Persa OD. High ROR1 Expression Is Associated With Poor Differentiation and Perineural Invasion in Cutaneous Squamous Cell Carcinoma. Experimental Dermatology. 2025. doi:10.1111/exd.70185
BibTeX
@article{Foerster2025,
author = {Foerster, Yannick and Mayer, Kristine E and Biedermann, Tilo and Persa, Oana-Diana},
title = {High ROR1 Expression Is Associated With Poor Differentiation and Perineural Invasion in Cutaneous Squamous Cell Carcinoma},
journal = {Experimental Dermatology},
year = {2025},
doi = {10.1111/exd.70185}
}
EUVIMED